docetaxel anhydrous has been researched along with Eosinophilia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bousquet, G; Hamdan, D; Janin, A; Le Foll, C; Leboeuf, C | 1 |
| Bousquet, G; Hamdan, D; Janin, A; Jourdan, N; Leboeuf, C; Pereira, C; Verneuil, L | 1 |
2 other study(ies) available for docetaxel anhydrous and Eosinophilia
| Article | Year |
|---|---|
Re-exploring immune-related side effects of docetaxel in an observational study: Blood hypereosinophilia.
Topics: Antineoplastic Agents; Docetaxel; Drug Hypersensitivity; Eosinophilia; Humans; Leukocyte Count; Middle Aged | 2019 |
A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Docetaxel; Drug Hypersensitivity; Eosinophilia; Female; Gastrointestinal Tract; Humans; Taxoids | 2015 |